Earnings call transcript: Carlisle Q1 2026 EPS beats forecast, stock rises

Carlisle reported Q1 2026 EPS of $3.63, beating estimates by 8.36%, while revenue was roughly flat to slightly below expectations at about $1.05-$1.1 billion and down 4% year over year. Adjusted EBITDA margin expanded 50 bps to 22.3%, and the stock rose 2.89% after hours, supported by a reaffirmed 2026 outlook for low-single-digit revenue growth and about 50 bps of margin expansion. Management also flagged new product launches, including ThermaThin R7 insulation, and continued aggressive buybacks.

Analysis

CSL is turning a macro cost shock into a pricing and mix test: the near-term margin lever is not demand, but whether the company can keep price ahead of petrochemical inflation without leaking volume. The fact pattern favors incumbents with strong contractor relationships and national scale; smaller roofing suppliers and distributors with less specification power are more exposed to input-cost pass-through lag and customer pushback. In that setup, CSL’s service model and product cadence should help defend share, while CWT looks like the cleaner operating leverage story because even modest volume stabilization plus footprint/actions can translate into outsized margin recovery.

The second-order risk is that this becomes a delayed-demand issue rather than a pure cost pass-through issue. If pricing lands into a weak new-construction backdrop, some projects can slip one or two quarters, which matters more for non-recurring volumes than for reroofing; that would temporarily flatten the revenue benefit from price while keeping raw-material pressure visible in reported gross margin. The timing matters: Q2 should show whether distributors accept the new price architecture or start to destock again, and Q3 is when the real P&L benefit should show up if pass-through holds.

The market may be underappreciating how much of the full-year setup is now a self-help story, not a housing story. CSL is effectively saying it can deliver low-double-digit top-line growth even without meaningful new-construction recovery, which implies the stock should trade more on execution credibility than on housing beta for the next 2-3 quarters. The contrarian angle is that if geopolitical pressure eases faster than expected, raw inflation can roll over before price fully sticks, creating a temporary revenue headwind but a better second-half margin setup—so the near-term stock reaction may be too linear relative to the eventual earnings path.

Key Decisions for Investors

• Long CSL vs short BLD for the next 1-2 quarters: CSL has better near-term pricing power and reroofing mix, while BLD is more exposed to housing softness and less able to offset raw-cost volatility.
• Add to CSL on any post-earnings dip, targeting a 6-9 month hold: the risk/reward favors a rerating if Q2 confirms price stickiness and Q3 shows margin translation; stop if distributor behavior indicates destocking or project deferrals widen.
• Trade CSL/CWT as a pair only on weakness in CWT: long CWT against a smaller CSL leg if you want more operating leverage, but size modestly because CWT has the higher execution risk and more cyclical exposure.
• Use CSL call spreads for Q3/Q4 2026 upside: the catalyst window is the back half when new product launches and price realization should finally show in earnings, with limited downside versus outright equity.
• Avoid shorting national building-products names broadly on this print; instead, short the weakest raw-material pass-through names in the roofing supply chain, where margin compression can arrive before price resets.